Prevalence of SARS-CoV-2, Verona, Italy, April-May 2020.

Massimo Guerriero, Zeno Bisoffi, Albino Poli, Claudio Micheletto, Antonio Conti, Carlo Pomari

Author Information

PMID: 33261716 DOI: 10.3201/eid2701.202740

We used random sampling to estimate the prevalence of severe acute respiratory syndrome coronavirus 2 infection in Verona, Italy. Of 1,515 participants, 2.6% tested positive by serologic assay and 0.7% by reverse transcription PCR. We used latent class analysis to estimate a 3.0% probability of infection and 2.0% death rate.

2019 novel coronavirus disease COVID-19 IgG Italy RT-PCR SARS-CoV-2 coronavirus coronavirus disease latent class analysis random sample survey respiratory infections severe acute respiratory syndrome coronavirus 2 viruses zoonoses

Lancet. 2020 Feb 15;395(10223):514-523 [PMID: 31986261]
J Clin Med. 2020 May 21;9(5): [PMID: 32455807]
Euro Surveill. 2020 Jan;25(3): [PMID: 31992387]
J Travel Med. 2020 May 18;27(3): [PMID: 32109273]
N Engl J Med. 2020 May 28;382(22):2081-2090 [PMID: 32329971]
Stat Methods Med Res. 2000 Jun;9(3):231-48 [PMID: 11084706]
N Engl J Med. 2020 Mar 12;382(11):1070-1072 [PMID: 32050059]
Int J Infect Dis. 2020 May;94:154-155 [PMID: 32179137]

Adult

Aged

COVID-19

Female

Humans

Italy

Male

Middle Aged

Prevalence

Reverse Transcriptase Polymerase Chain Reaction

SARS-CoV-2

Serologic Tests

Journal Article

Two-Year Cohort Study of SARS-CoV-2, Verona, Italy, 2020‒2022.SARS-CoV-2 Circulation during the First Year of the Pandemic: A Seroprevalence Study from January to December 2020 in Tuscany, Italy.SARS-CoV-2 Infection in Health Workers: Analysis from Verona SIEROEPID Study during the Pre-Vaccination Era.Prevalence of and factors associated with COVID-19 diagnosis in symptomatic patients followed in general practices in Germany between March 2020 and March 2021.

OpenLB
Open Library of Bioscience